#FAME3 trial was recently published in #NEJM. Patients with three-vessel coronary artery disease have been found to have better outcomes with coronary-artery bypass grafting (#CABG) than with percutaneous coronary intervention (#PCI), but studies in which PCI is guided by measurement of fractional flow reserve (#FFR) have been lacking. The current trial tried to fill in the knowledge gap.